Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03233997 · ClinicalTrials.gov registry record · NA
CSD170302: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes
A NA study, sponsored by RAI Services Company.
- Completed
- Registry status
- NA
- Development phase
- 121
- Enrollment target
NCT03233997: Completed NA study, sponsored by RAI Services Company.
NCT03233997 is a NA study that has completed, run by RAI Services Company. The registered enrollment target is 121 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03233997, a NA study, has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- NA
- Development phase
- 121 participants
- Enrollment target
Study Summary
To determine the rate and amount of nicotine uptake with 10-minute ad libitum use of four different marketed electronic cigarettes. Furthermore, to measure overall product liking by subjects to assess potential willingness to seek out the Electronic Cigarette (EC) again in the future.
Primary Outcome
To assess nicotine uptake with the start of a 10-minute ad libitum Investigational Product (IP) use period.
Interventions
- OTHER FT21018
- OTHER FT21033
- OTHER FT21034
- OTHER FT21035
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2017-07-18 |
| Est. Completion | 2017-09-30 |
| Phase | NA |
What the finished NCT03233997 record still lists
NCT03233997 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 4 interventions - of which FT21018 is the first listed.
NCT03233997 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03233997 about?
NCT03233997 is a clinical study titled "CSD170302: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes". To determine the rate and amount of nicotine uptake with 10-minute ad libitum use of four different marketed electronic cigarettes. Furthermore, to measure overall product liking by subjects to assess potential willingness to seek out the Electronic Cigarette (EC) again in the future.
What is the current status of trial NCT03233997?
This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2017-07-18. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT03233997?
The interventions under investigation include: FT21018 (OTHER), FT21033 (OTHER), FT21034 (OTHER), FT21035 (OTHER).
Who is sponsoring clinical trial NCT03233997?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03233997's enrollment target sits among peer trials
121 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI